Dive deep into the 11 hidden risks in our latest blog post: #Healthcare #GLP1Therapy #RiskAwareness To view or add a comment, sign in More Relevant Posts GLP-1 therapies are at a crossroads
If cholelithiasis or cholecystitis are suspected, gallbladder studies are indicated ADVERSE REACTIONS Most common (5%) in clinical trials: injection-site nodule (10.5%), nausea (8.2%)
How Dihexa Works (Proposed and Partly Retracted) The proposed mechanism is that Dihexa potentiates hepatocyte growth factor (HGF) signaling at the c-Met (MET) receptor, downstream of PI3K-AKT, driving dendritic spine formation and synaptogenesis
Staff can pull the infusion record straight from the patients chart instead of reconstructing it after the fact, which cuts the documentation gaps that lead to post-payment audits
(i.e., if three 0.5 ml vials are dispensed, report ML 1.5)